GWP Trademark

Trademark Overview


On Tuesday, March 18, 2014, a trademark application was filed for GWP with the United States Patent and Trademark Office. The USPTO has given the GWP trademark a serial number of 86224718. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Wednesday, October 21, 2015. This trademark is owned by GW Pharma Limited. The GWP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schiz...
gwp

General Information


Serial Number86224718
Word MarkGWP
Filing DateTuesday, March 18, 2014
Status713 - CANCELLED - SECTION 18
Status DateWednesday, October 21, 2015
Registration Number4662404
Registration DateTuesday, December 30, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateWednesday, October 21, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Party NameGW Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Party NameGW Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Trademark Events


Event DateEvent Description
Wednesday, October 21, 2015CANCELLED SECTION 18-TOTAL
Wednesday, October 21, 2015CANCELLATION TERMINATED NO. 999999
Friday, October 9, 2015CANCELLATION GRANTED NO. 999999
Friday, March 20, 2015CANCELLATION INSTITUTED NO. 999999
Tuesday, December 30, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, November 25, 2014Sec. 1(B) CLAIM DELETED
Tuesday, November 25, 2014WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Friday, November 21, 2014TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 29, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 28, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 28, 2014FINAL REFUSAL E-MAILED
Thursday, August 28, 2014FINAL REFUSAL WRITTEN
Thursday, August 7, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 30, 2014ASSIGNED TO LIE
Friday, July 25, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 23, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 23, 2014NON-FINAL ACTION E-MAILED
Monday, June 23, 2014NON-FINAL ACTION WRITTEN
Friday, June 20, 2014ASSIGNED TO EXAMINER
Wednesday, April 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 21, 2014NEW APPLICATION ENTERED IN TRAM